EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

High-Throughput Screening Tool to Identify Small Molecule Inhibitors of Telomerase

Elisa Aquilanti iD, Sulyman Barkho, Vincent Bozinov, Lauren Kageler, Max Garrity-Janger, Michael F Mesleh, Steven Horner, Matthew J Ranaghan, Matthew Meyerson

ACS Chemical Biology · 2025

DOI: 10.1021/acschembio.5c00244 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Biology, 2025. Verfasst von Elisa Aquilanti und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neuro Oncology, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02215, United States. Hauptthemen laut MEDLINE: Telomerase, High-Throughput Screening Assays, Enzyme Inhibitors, Small Molecule Libraries. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute, Damon Runyon Cancer Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TelomeraseHigh-Throughput Screening AssaysEnzyme InhibitorsSmall Molecule LibrariesHumansTriboliumAnimalsDrug Discovery

Substanzen

TelomeraseEnzyme InhibitorsSmall Molecule Libraries

Autor:innen und Institutionen

  • Division of Neuro Oncology, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02215, United States.
  • Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, United States.
  • Center for the Development of Therapeutics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, United States.
  • Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts 02115, United States.
  • Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02215, United States.
  • Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115, United States.

ORCID-Profile: Elisa Aquilanti

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • Damon Runyon Cancer Research Foundation

Zitieren

APA

Aquilanti, E., Barkho, S., Bozinov, V., Kageler, L., Garrity-Janger, M., Mesleh, M. F., Horner, S., Ranaghan, M. J., & Meyerson, M. (2025). High-Throughput Screening Tool to Identify Small Molecule Inhibitors of Telomerase. ACS Chemical Biology. https://doi.org/10.1021/acschembio.5c00244

Vancouver

Aquilanti E, Barkho S, Bozinov V, Kageler L, Garrity-Janger M, Mesleh MF, et al. High-Throughput Screening Tool to Identify Small Molecule Inhibitors of Telomerase. ACS Chemical Biology. 2025. doi:10.1021/acschembio.5c00244

BibTeX
@article{Aquilanti2025,
  author = {Aquilanti, Elisa and Barkho, Sulyman and Bozinov, Vincent and Kageler, Lauren and Garrity-Janger, Max and Mesleh, Michael F and Horner, Steven and Ranaghan, Matthew J and Meyerson, Matthew},
  title = {High-Throughput Screening Tool to Identify Small Molecule Inhibitors of Telomerase},
  journal = {ACS Chemical Biology},
  year = {2025},
  doi = {10.1021/acschembio.5c00244}
}
Kostenlos starten →